SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Corvus Pharmaceuticals stock extends eight-day losing streak

Corvus Pharmaceuticals (CRVS) is down eight consecutive trading days and trades at $10.10 as of 2:49:47 PM ET, down $0.31 (2.93%).

Corvus Pharmaceuticals, Inc. 93% -Would be lowest close since Jan. 05 -On pace for largest percent decrease since Oct. 87% over this period -Longest losing streak since Feb.

25, 2025, when it fell for eight straight trading days -Worst eight day stretch since the eight days ending Sept. 52 on Jan. 38% from 52 weeks ago (Oct. 52 on Jan.

50 on Jan. 82; lowest intraday level since Jan. 67% at today's intraday low; largest intraday percent decrease since Sept. 25% All data as of 2:49:47 PM ET Source: Dow Jones Market Data, FactSet (END) Dow Jones Newswires October 08, 2026 14:55 ET (18:55 GMT) Copyright (c) 2026 Dow Jones & Company, Inc.

The statements in this document shall not be considered as an objective or independent explanation of the matters. Please note that this document (a) has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and (b) is not subject to any prohibition on dealing ahead of the dissemination or publication of investment research.